CorMedix Inc. (CRMD) is a clinical-stage biopharmaceutical company based in Berkeley Heights, New Jersey, committed to developing and commercializing innovative therapies for unmet needs in infectious and inflammatory diseases. The company boasts a promising pipeline focused primarily on infection prevention and the management of inflammatory conditions, enhancing patient care and outcomes. CorMedix's strategic determination to tackle significant healthcare challenges positions it favorably in the competitive biopharmaceutical landscape, presenting institutional investors with a compelling growth opportunity within the dynamic healthcare sector. Show more
Location: 300 CONNELL DRIVE, BERKELEY HEIGHTS, NJ, UNITED STATES, 07922, Berkeley Heights, NJ, 07922, USA | Website: https://www.cormedix.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
611.4M
52 Wk Range
$5.60 - $17.43
Previous Close
$8.02
Open
$8.09
Volume
2,356,760
Day Range
$7.66 - $8.15
Enterprise Value
725.1M
Cash
48.49M
Avg Qtr Burn
N/A
Insider Ownership
7.82%
Institutional Own.
63.36%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
DefenCath® (taurolidine and heparin) Details Infectious disease, Catheter related blood stream infections | Approved Quarterly sales | |
DefenCath® (taurolidine and heparin) Details Infectious disease, Catheter related blood stream infections, TPN patients | NDA Submission | |
REZZAYO (rezafungin) Details Prophylaxis of Fungal Infections | Phase 3 Data readout |